Similar articles

• Clinical outcomes and genome-wide association for a brain methylation site in an antidepressant pharmacogenetics study in Mexican Americans.

  Wong ML, Dong C, Flores DL, Ehrhart-Bornstein M, Bornstein S, Arcos-Burgos M, Licinio J. Wong ML, et al. Am J Psychiatry. 2014 Dec 1;171(12):1297-309. doi: 10.1176/appi.ajp.2014.12091165. Epub 2014 Oct 31. Am J Psychiatry. 2014. PMID: 25220861 Free PMC article. Clinical Trial.
• The SSRIs drug Fluoxetine, but not the noradrenergic tricyclic drug Desipramine, improves memory performance during acute major depression.

  Levkovitz Y, Caftori R, Avital A, Richter-Levin G. Levkovitz Y, et al. Brain Res Bull. 2002 Aug 15;58(4):345-50. doi: 10.1016/s0361-9230(01)00780-8. Brain Res Bull. 2002. PMID: 12183009 Clinical Trial.
• Tianeptine and fluoxetine in major depression: a 6-week randomised double-blind study.

  Novotny V, Faltus F. Novotny V, et al. Hum Psychopharmacol. 2002 Aug;17(6):299-303. doi: 10.1002/hup.411. Hum Psychopharmacol. 2002. PMID: 12404675 Clinical Trial.
• The treatment of depression in patients maintained on dialysis.

  Finkelstein FO, Watnick S, Finkelstein SH, Wuerth D. Finkelstein FO, et al. J Psychosom Res. 2002 Oct;53(4):957-60. doi: 10.1016/s0022-3999(02)00306-9. J Psychosom Res. 2002. PMID: 12377309 Review. No abstract available.
• Augmentation strategies with serotonergic-noradrenergic combinations.

  Nelson JC. Nelson JC. J Clin Psychiatry. 1998;59 Suppl 5:65-8; discussion 69. J Clin Psychiatry. 1998. PMID: 9635550 Review.